跨男性谱系人群的避孕
本文综述睾酮对性类固醇轴的影响及闭经期间仍可能排卵和妊娠的机制,提供性别包容术语和获取性别肯定性性史的示例脚本,讨论避孕方法对性别烦躁和性别肯定的影响,并给出跨男性人群避孕咨询模型。指南由跨性别经历的生殖照护临床医生主导制定。
要点
- 许多临床医生和跨男性个体错误认为闭经期间无妊娠风险。
- 跨男性人群的避孕和妊娠咨询实践不一致,缺乏有力临床指导。
- 临床医生报告缺乏跨性别生殖健康培训,许多人不愿治疗跨性别患者。
核心结论
- 本文整合既往研究,为跨男性患者的避孕管理提供全面临床指导。
研究设计与样本
- 本文为综述类文章,检索范围未在摘要中报告。
主要发现
- 许多临床医生和跨男性个体错误认为闭经期间无妊娠风险。
- 跨男性人群的避孕和妊娠咨询实践不一致,缺乏有力临床指导。
- 临床医生报告缺乏跨性别生殖健康培训,许多人不愿治疗跨性别患者。
关键数值与推荐
- 本文提供性别包容术语和获取性别肯定性性史的示例脚本。
- 本文讨论可用避孕方法对性别烦躁和性别肯定的影响及副作用。
- 本文提供跨男性人群避孕咨询模型以助决定避孕需求和类型选择。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The field of transgender health continues to expand rapidly, including research in the area of family planning. While much attention has been given to fertility preservation and the parenting intentions of transgender individuals, far less has been paid to pregnancy prevention and contraceptive needs of people along the transmasculine gender spectrum (transgender men and gender-nonbinary persons who were assigned female at birth). Existing research illustrates that many clinicians and transmasculine individuals falsely believe that there is no risk of pregnancy while amenorrheic. These studies also show inconsistent counseling practices provided to transmasculine persons surrounding contraception and pregnancy while falling short of providing robust clinical guidance for improvement. Clinicians report a lack of adequate training in transgender reproductive health, and consequently, many do not feel comfortable treating transgender patients. The aim of this publication is to consolidate the findings of these prior studies and build upon them to offer comprehensive clinical guidance for managing contraception in transmasculine patients. To do so, it reviews the physiologic effects of testosterone on the sex steroid axis and current understanding of why ovulation and pregnancy may still occur while amenorrheic. Gender-inclusive terminology and a suggested script for eliciting a gender-affirming sexual history are offered. Common concerns (such as the effects on gender dysphoria and gender affirmation) and side effects of available contraceptive methods are subsequently addressed and how these may have a unique impact on transmasculine persons as compared with cisgender women. Lastly, a model is provided for approaching contraceptive counseling in the transmasculine population to assist clinicians and patients in determining the need for and selection of the type of contraception. To center transmasculine voices, the development of this publication's guidelines have been led by reproductive care clinicians of transgender experience.
引用
- Krempasky C, Harris M, Abern L, et al. Contraception across the transmasculine spectrum. Am J Obstet Gynecol. 2019. PMID: 31394072. doi:10.1016/j.ajog.2019.07.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。